Funds
Andurand Capital’s flagship commodities hedge fund has deepened its losses this year, dropping 52% year-to-date after a sharp April selloff driven by mounting global trade tensions, according to a report by Bloomberg.
Robert Gibbins, founder of Autonomy Capital Research, is preparing to reopen his hedge fund to external investors after a sharp turnaround in performance driven by what he calls a “modern macro” strategy focused on technological disruption as a macroeconomic force, according to a report by Bloomberg.
Peconic Partners, the New York-based hedge fund led by veteran investor Bill Harnisch, is up 13% month-to-date in April, buoyed by well-timed short positions and a defensive approach amid mounting macroeconomic uncertainty, according to a report by Bloomberg.
Greenlight Capital delivered a strong 8.2% return in Q1 2025, significantly outperforming the broader hedge fund universe and the S&P 500, driven largely by a concentrated bet on gold, according to a report by Reuters citing founder David Einhorn’s latest investor letter.
Whale Rock Capital Management posted a sharp 20% loss in the first quarter of 2025, as renewed trade tensions under the Trump administration sparked a rout in public equities — with tech and growth names hit particularly hard, according to a report by Bloomberg.
3iQ Corp, a specialist in digital asset investment solutions, is to launch trading in the 3iQ Solana Staking ETF, which numbers SkyBridge Capital among its largest unit holders, on the Toronto Stock Exchange on 16 April.
Systematica Investments’ listed version of its flagship hedge fund, Schroder GAIA BlueTrend, has dropped approximately 19% year-to-date, reflecting the mounting pressure on trend-following strategies, according to a report by the Financial Times.
Hedge funds saw a performance setback in March, with the SS&C GlobeOp Hedge Fund Performance Index recording a gross return of -1.61%, according to the latest data released by SS&C Technologies.
Armistice Capital’s flagship hedge fund suffered its steepest monthly loss since inception, plunging 18.4% in March, as volatile markets and steep declines in healthcare and consumer stocks hammered performance, according to a report by Bloomberg.
Man Group’s flagship quant strategies are facing steep losses in 2025, with several funds down double digits year-to-date as heightened market volatility tests the resilience of trend-following models, according to a report by Bloomberg.
